FindTrial
Sign In

Effects of oral branched chain amino acids (BCAA) supplementation in liver function and QOL after liver resection for hepatocellular carcinoma with liver cirrhosis

Effects of oral branched chain amino acids (BCAA) supplementation in liver function and QOL after liver resection for hepatocellular carcinoma with liver cirrhosis - Effects of oral branched chain amino acids (BCAA) supplementation after liver resection for hepatocellular carcinoma

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000001361
Enrollment
60
Registered
2008-09-15
Start date
2006-10-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular carcinoma with liver cirrhosis

Interventions

Oral branched chain amino acids from 5 day to 28 day after liver resecton diet for liver cirrhosis

Sponsors

Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Patients planed liver resection for hepatocellular carcinoma with liver cirrhosis 2)no gender 3)Written informed consent for patients or

Exclusion criteria

Exclusion criteria: 1)over 76 years old 2)ICG-R15: 35-40% 3)asites ineffective with a diuretic 4)jaundice 5)liver damage: grade C 6)an allergy to milk 7)renal damage: over Cr 2.0mg/dl 8)primary aminoaciduria 9)pregnant or nursing woman 10)unsutable patients

Design outcomes

Primary

MeasureTime frame
Liver function and QOL—

Countries

Japan

Contacts

Public ContactHiroaki Nagano

Graduate School of Medicine, OSAKA University Department of Gastroenterological Surgery

06-6879-3251

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026